<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We present a case of <z:hpo ids='HP_0011009'>acute</z:hpo> pulmonary <z:hpo ids='HP_0000969'>oedema</z:hpo> as the first presentation of autoimmune <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> in primary <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> syndrome in a patient who had no previous cardiac history </plain></SENT>
<SENT sid="1" pm="."><plain>Five days of <z:chebi fb="0" ids="6888">methylprednisolone</z:chebi> at 500 mg/day followed by 100 mg/day for 10 days and then a weaning course of oral <z:chebi fb="0" ids="8382">prednisone</z:chebi> resulted in effective resolution of the <z:hpo ids='HP_0011009'>acute</z:hpo> diffuse <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Her cardiac status became clinically and echocardiographically <z:mpath ids='MPATH_458'>normal</z:mpath> </plain></SENT>
<SENT sid="3" pm="."><plain>We illustrate the effectiveness of immunosuppressive therapy as an adjunct to standard anti-failure measures in such presentations and we outline the association between <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> and cardiac dysfunction </plain></SENT>
</text></document>